Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for pain relief and appetite stimulation in advanced cancer
2011-001739-21Phase 2Active
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cannabidiol in cancer pain, anorexia nervosa (AN) and Malnutrition, sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Primary endpoint: IVRS 11-point Numeric Rating Scale pain score (average pain). Started Mar 2012; status: active.
02
Drugs
cannabidiol
03
Conditions
cancer painanorexia nervosa (AN)Malnutrition
Beyond the preview
Go deeper on 2011-001739-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001739-21.